The American company Johnson & Johnson has encountered a setback in the development of a vaccine against Covid-19.
The company has temporarily halted its development.
The pharmaceutical company announced that a test subject has unexpectedly become ill, according to documents in possession of the news medium Stat News.
In total, 60,000 people participate in clinical tests.
What exactly is going on is still unclear. Johnson & Johnson does not want to explain the decision yet.